Order Article Reprints

Boyd LNC, Ali M, Kam L, Puik JR, Rodrigues SMF, Zwart ES, Daams F, Zonderhuis BM, Meijer LL, Le Large TYS, et al. The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach. Cancers. 2022; 14(2):344. https://doi.org/10.3390/cancers14020344

Boyd, Lenka N. C., Mahsoem Ali, Laura Kam, Jisce R. Puik, Stephanie M. Fraga Rodrigues, Eline S. Zwart, Freek Daams, Barbara M. Zonderhuis, Laura L. Meijer, Tessa Y. S. Le Large, and et al. 2022. "The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach" Cancers 14, no. 2: 344. https://doi.org/10.3390/cancers14020344

Boyd, L. N. C., Ali, M., Kam, L., Puik, J. R., Rodrigues, S. M. F., Zwart, E. S., Daams, F., Zonderhuis, B. M., Meijer, L. L., Le Large, T. Y. S., Giovannetti, E., van Laarhoven, H. W. M., & Kazemier, G. (2022). The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach. Cancers, 14(2), 344. https://doi.org/10.3390/cancers14020344